Navigation Links
Mylan Reports Adjusted Diluted EPS of $0.53 for the Quarter, an 18% Increase Over Prior Year Quarter; and $2.04 for the Year, a 27% Increase Over Prior Year
Date:2/21/2012

the Company's revenues for the three months and years ended December 31, 2011, and 2010, is included at the end of this release.

Third party net revenues from Mylan's Generics segment, which are derived from sales in North America, Europe, the Middle East and Africa (collectively, EMEA) and Australia, India, Japan and New Zealand (collectively, Asia Pacific) were $1.42 billion in the three months ended December 31, 2011, compared to $1.35 billion in the comparable prior year period, representing an increase of $72.7 million or 5.4% or an increase of approximately 7% when excluding the unfavorable effect of foreign currency translation.

Third party net revenues from North America were $737.1 million for the three months ended December 31, 2011, compared to $647.5 million for the comparable prior year period, representing an increase of $89.5 million or 13.8%.  The increase in third party revenues was principally due to sales of new products which totaled approximately $71.4 million in the current quarter. The remaining increase was principally due to favorable volumes on existing products. The effect of foreign currency translation was insignificant within North America.

Third party net revenues from EMEA were $347.4 million for the three months ended December 31, 2011, compared to $397.0 million for the comparable prior year period, a decrease of $49.6 million, or 12.5%. Translating current quarter third party net revenues from EMEA at prior year comparative period exchange rates would have resulted in a decline in third party net revenues, excluding the effect of foreign currency, of approximately $46 million, or 12%. This decrease was mainly the result of unfavorable pricing and volume in many of the European markets in which Mylan operates, partially offset by new product launches and higher local currency revenues in Italy and Spain.

Third party net revenues in Asia Pacific were $337.9 million for the three months ended Decembe
'/>"/>

SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Mylan and Pfizer Announce Epinephrine Auto-injector Settlement Agreement
2. Mylan to Change Name of Specialty Subsidiary From Dey Pharma to Mylan Specialty
3. Mylan Actively Addressing Shortage of Preservative-Free Methotrexate Injection
4. Mylan CEO Heather Bresch Testifies Before Congress in Support of Generic Drug User Fee Program and Urges Update of Federal Food, Drug and Cosmetic Act of 1938 to Create a Level Playing Field for Manufacturers
5. Mylan Completes Acquisition of Two Limited-Competition Dermatological Products from Valeant
6. Valeant Pharmaceuticals Completes Divestiture of Generic Dermatology Products to Mylan
7. Mylan Receives Tentative FDA Approval for Generic Version of Lipitor®
8. Mylan to Host Investor Day on Feb. 21, 2012, in New York City
9. Mylan Launches Innovative Version of Antiepileptic Drug Levetiracetam
10. Mylan Launches First Generic Version of Teveten® Tablets
11. Mylan Receives Approval for First-to-File Generic Keppra XR® Extended-Release Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... what is a first formal tie-up for the two organizations, ... are co-organizing the BPMDS Symposium China Forum ... China South 2015 exhibition at Shenzhen Convention & Exhibition Center. ... device manufacturers in going abroad. This is the ... China . Furthermore, MEDTEC China South will provide ...
(Date:4/1/2015)... HONG KONG , April 1, 2015 ... stock code: 2211) announced that Mr. Jin Dongtao, chairman ... of the Company, representing 2% of the existing entire ... Limited, at HK$2.82 per share with the total amount ... transaction, Mr. Jin Dongtao,s shareholding will increase from 45.17% ...
(Date:4/1/2015)... April 1, 2015  Medelita® has renewed a commitment ... United States who have exhibited leadership in ... In its inaugural year, "The Right Fit H.E.R.O. Honorarium" ... nominations were narrowed to 10 through a series of ... 10,000 votes from colleagues in medicine, friends, and family.  ...
Breaking Medicine Technology:MEDTEC & NAMSA Co-organize BPMDS Symposium China 2MEDTEC & NAMSA Co-organize BPMDS Symposium China 3Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 2Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 3Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 4Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 5Second Annual $25,000 Honorarium for Exceptional Medical Residents to Accept Nominations in April 2015 2Second Annual $25,000 Honorarium for Exceptional Medical Residents to Accept Nominations in April 2015 3Second Annual $25,000 Honorarium for Exceptional Medical Residents to Accept Nominations in April 2015 4
... LISBON, Portugal, September 11 , ... New Intranasal Treatment,for Breakthrough Cancer Pain Over OTFC , ... efficacy of Instanyl in,management of breakthrough cancer pain. The data ... of Chapters of the International,Association for the Study of Pain ...
... , , Letters of Intent due ... DES PLAINES, Ill., Sept. 10 The American Brain Tumor Association has launched ... ideas for solving the challenges of brain tumor diagnosis and treatment. , ... the past decade resulting in better treatments and longer lives for many patients, ...
Cached Medicine Technology:Instanyl(R) (intranasal fentanyl spray) Sets New Standard in Management of Breakthrough Cancer Pain 2Instanyl(R) (intranasal fentanyl spray) Sets New Standard in Management of Breakthrough Cancer Pain 3Instanyl(R) (intranasal fentanyl spray) Sets New Standard in Management of Breakthrough Cancer Pain 4American Brain Tumor Association Calls for Discovery Research 2
(Date:4/1/2015)... Arroyo Grande, CA, March 24, 2015 (PRWEB) April 01, 2015 ... is considered by many, the most extreme jungle adventure you ... to as many as 23 days. Endorsed by the Philippine ... , ”Many people have visited the rainforest, but very few ... said Johan Bergman, Chief Adventure Officer. , Armed with nothing ...
(Date:4/1/2015)... New York (PRWEB) April 01, 2015 ... hundreds of Risperdal lawsuits ( http://www.risperdallawsuit2014.com/ ) has ... the calendar for the Philadelphia Court of Common Pleas, ... Room 206, City Hall. Court records indicate that the ... filed on behalf of Risperdal users who experienced gynecomastia ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 SCI ... patient scheduling platform, today announced that CEO Joel French ... Annual HIMSS Conference & Exhibition in Chicago, April ... Growth with Better Provider Care Coordination Strategies ” with ... at 12 p.m. CDT. More than 38,000 healthcare industry ...
(Date:4/1/2015)... 01, 2015 OSF Saint Paul Medical ... System , was welcomed into the Ministry April 1, ... Msgr. Paul E. Showalter, vicar general of the Catholic ... Dedication culminated a nearly year-long transition process for the ... hospital. Speakers for the morning ceremony included Sister Judith ...
(Date:4/1/2015)... IQ Formulations , one of the ... companies in the U.S., today is commending GNC for taking ... standards for its herbal supplements.* GNC vowed that its new ... the accuracy of labeling on its products. , In ... Formulations CEO Jay Cohen said: , “In a ...
Breaking Medicine News(10 mins):Health News:Pennsylvania Court Overseeing Hundreds of Risperdal Lawsuits Schedules April Meeting 2Health News:Pennsylvania Court Overseeing Hundreds of Risperdal Lawsuits Schedules April Meeting 3Health News:SCI Solutions CEO Joel French and Northeast Georgia Health System to Present at HIMSS15 2Health News:SCI Solutions CEO Joel French and Northeast Georgia Health System to Present at HIMSS15 3Health News:SCI Solutions CEO Joel French and Northeast Georgia Health System to Present at HIMSS15 4Health News:Mendota Community Hospital Now OSF Saint Paul Medical Center 2Health News:Mendota Community Hospital Now OSF Saint Paul Medical Center 3Health News:IQ Formulations Applauds GNC for Enhancing Its Testing and Quality Control Processes for Herbal Supplements 2
... N.J., June 10 Fingertip Formulary(R), the leading ... formulary data, introduces a free, customized mobile solution, ... may now access Fingertip Formulary,s simple-to-use formulary lookup ... iPhone. By having formulary data available at the ...
... ... use as well as usage frequency for up to 90 days, equipping parents with a valuable ... Mart Store. , ... June 10, 2009 -- A new home-based hair follicle drug test kit called HairConfirm™ can detect ...
... ... EHR/PM System to Help Physicians, Organization Deliver on Its Commitment to Clinically Integrate Member ... Dallas, ... healthcare software solutions for physician practices, announced today that after more than two years ...
... ... Lexington, Columbia and Midlands area of South Carolina to reach their weight loss goals ... to her list of impressive medical credentials. , ... Columbia, SC (PRWEB) June 10, 2009 -- Columbia Physician, ...
... According to a research abstract that will be presented ... Meeting of the Associated Professional Sleep Societies, symptoms of Rheumatoid ... by pain, depression and poor adherence to RA medications. ... RA diagnosis, RA disease activity, level of pain, depression symptoms ...
... ACROSS STATES , , WASHINGTON, June 10 A ... elimination of racial disparities in health, women of color in ... a variety of measures of health, health care access and ... by the Kaiser Family Foundation. , , The report, ...
Cached Medicine News:Health News:Fingertip Formulary Mobile(R) Now Offers Access to Real-Time Formulary Data on the iPhone 2Health News:‘HairConfirm' Is First Drug Test of Its Kind to Report Low/Medium/High Usage; Now Available at Local Discount Drug Marts 2Health News:‘HairConfirm' Is First Drug Test of Its Kind to Report Low/Medium/High Usage; Now Available at Local Discount Drug Marts 3Health News:The Physicians' Organization of the University Medical Center at Princeton Chooses iMedica's EHR and Practice Management Solutions 2Health News:The Physicians' Organization of the University Medical Center at Princeton Chooses iMedica's EHR and Practice Management Solutions 3Health News:Pamela Lyon, M.D. Achieves Board Certification in Bariatric, Weight Loss Medicine 2Health News:Sizable Health Disparities Evident in Every State Between Women of Different Racial and Ethnic Groups 2Health News:Sizable Health Disparities Evident in Every State Between Women of Different Racial and Ethnic Groups 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: